Prognostic analysis using the GEPIA database also indicated that high HOXA11-AS levels in a variety of tumors, including adrenocortical cancer (ACC), kidney papillary cell carcinoma (KIRP), LGG, and pancreatic cancer (PAAD), were associated with poor overall survival (OS) and recurrence-free survival (RFS) (Fig. S2B–C). This evidence concerns the gene HOXA11 and familial pancreatic carcinoma.